These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine. Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N. Eur J Pharmacol; 2013 Mar 05; 703(1-3):53-61. PubMed ID: 23276665 [Abstract] [Full Text] [Related]
4. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro. Ye CY, Lei Y, Tang XC, Zhang HY. Neuropharmacology; 2015 Aug 05; 95():29-36. PubMed ID: 25744714 [Abstract] [Full Text] [Related]
6. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease. Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. ChemMedChem; 2015 Nov 05; 10(11):1863-74. PubMed ID: 26412714 [Abstract] [Full Text] [Related]
7. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration. Laursen B, Mørk A, Plath N, Kristiansen U, Bastlund JF. Brain Res; 2014 Jan 16; 1543():253-62. PubMed ID: 24231553 [Abstract] [Full Text] [Related]
8. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC. Exp Neurol; 2015 May 16; 267():219-29. PubMed ID: 25747037 [Abstract] [Full Text] [Related]
10. DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway. Zhou D, Zhou W, Song JK, Feng ZY, Yang RY, Wu S, Wang L, Liu AL, Du GH. Acta Pharmacol Sin; 2016 Nov 16; 37(11):1401-1412. PubMed ID: 27498773 [Abstract] [Full Text] [Related]
11. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease. Hao YN, Lu QX, Zhai YH, Wang HY, Wu MN, Hu MM, Yang B, Wang ZJ, Wu ZW, Qi JS. Brain Res Bull; 2018 Oct 16; 143():116-122. PubMed ID: 30366065 [Abstract] [Full Text] [Related]
15. Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice. Shao BY, Xia Z, Xie Q, Ge XX, Zhang WW, Sun J, Jiang P, Wang H, Le WD, Qiu ZB, Lu Y, Chen HZ. CNS Neurosci Ther; 2014 Feb 16; 20(2):165-71. PubMed ID: 24279603 [Abstract] [Full Text] [Related]
16. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease. Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M. J Neurol Sci; 2013 Dec 15; 335(1-2):145-54. PubMed ID: 24095271 [Abstract] [Full Text] [Related]
19. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier. Prinz M, Parlar S, Bayraktar G, Alptüzün V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, Förster C, Turunc E, Armagan G, Yalcin A, Schiller C, Leuner K, Krug M, Sotriffer CA, Holzgrabe U. Eur J Pharm Sci; 2013 Jul 16; 49(4):603-13. PubMed ID: 23643737 [Abstract] [Full Text] [Related]
20. Attenuating Aβ1-42-induced toxicity by a novel acetylcholinesterase inhibitor. Mishra N, Sasmal D, Singh KK. Neuroscience; 2013 Oct 10; 250():309-19. PubMed ID: 23872389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]